Interoceptive Exposure for Eating Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial compares two psychological treatments for teenagers with low-weight eating disorders. It examines how Interoceptive Exposure Treatment (IE), which focuses on confronting food and body image fears, compares to Family-Based Therapy (FBT), where families encourage eating and reduce food avoidance. The goal is to determine which treatment more effectively improves body weight and reduces the impact of eating disorders on daily life. Teens aged 12-18 who struggle with food intake and maintaining a healthy weight might be suitable candidates for this trial. As an unphased trial, this study provides a unique opportunity for teens to contribute to important research that could shape future treatment approaches.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but if you recently started psychiatric medication or changed the dosage within the last two weeks, you may not be eligible to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that both Interoceptive Exposure Treatment (IE) and Family-Based Treatment (FBT) are generally safe for treating eating disorders. IE, particularly in teenagers, has shown promise with few reported side effects. This treatment involves gradually confronting avoided situations, such as certain foods or body image concerns, and has been successfully used in other exposure therapies for eating disorders.
FBT is well-tolerated and serves as a leading treatment for teenagers with anorexia nervosa. Studies have demonstrated FBT's effectiveness and safety, emphasizing family involvement in the recovery process. This approach is widely used and has strong evidence supporting its safety.
Both treatments aim to help patients gain healthy weight and improve their relationship with food. While individual experiences may vary, research supports the safety of these therapies for people with eating disorders.12345Why are researchers excited about this trial?
Researchers are excited about Interoceptive Exposure Treatment (IE) for eating disorders because it introduces a unique approach by directly targeting food avoidance and body image issues through exposure therapy. Unlike standard treatments that often focus on nutritional rehabilitation or cognitive restructuring, IE actively engages patients with their physical sensations and emotions related to eating. This method aims to reduce anxiety and avoidance behaviors by gradually increasing comfort with distressing feelings, potentially offering a more integrated and sustainable path to recovery. Meanwhile, Family-Based Treatment (FBT) remains a powerful comparator, emphasizing family involvement to change eating behaviors and attitudes toward food, enhancing the overall treatment landscape for eating disorders.
What evidence suggests that this trial's treatments could be effective for eating disorders?
Research has shown that Family-Based Treatment (FBT), one of the treatments in this trial, ranks among the top methods for treating eating disorders in teenagers, such as anorexia nervosa. It effectively involves parents in helping their children regain a healthy weight and eating habits. Studies also highlight its success in treating binge-eating disorder.
Interoceptive Exposure (IE) is another therapy under study in this trial for its potential to treat eating disorders in underweight individuals. It involves directly confronting fears related to food and body image. Early research suggests that combining IE with FBT could enhance treatment by reducing food avoidance and increasing body awareness.12356Who Is on the Research Team?
Thomas Hildebrandt, Psy.D.
Principal Investigator
Icahn School of Medicine at Mount Sinai
Are You a Good Fit for This Trial?
This trial is for English-speaking adolescents aged 12-18 with low weight eating disorders like anorexia. They must have a doctor's permission for outpatient care, show significant food intake restriction or avoidance, and be unable to maintain a healthy body weight. Those with substance dependence, bipolar/psychotic disorders, recent psychiatric medication changes, major medical illnesses, or active suicidal thoughts cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either Exposure-based Family Therapy (IE) or Family-Based Therapy (FBT) for low weight eating disorders
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Family-Based Treatment (FBT)
- Interoceptive Exposure Treatment (IE)
Family-Based Treatment (FBT) is already approved in European Union, United States, Canada for the following indications:
- Anorexia Nervosa
- Other Eating Disorders
- Anorexia Nervosa
- Other Eating Disorders
- Anorexia Nervosa
- Other Eating Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator